APO Research
Talk to an analyst

APO RESEARCH · REPORT

Psoriatic Arthritis Therapeutics Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Psoriatic Arthritis Therapeutics Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

30 December 2025191 pages

Choose your research edition.

Industry ResearchPsoriatic Arthritis Therapeutics Drug Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Psoriatic Arthritis Therapeutics Drug Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Psoriatic Arthritis Therapeutics Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Psoriatic Arthritis Therapeutics Drug Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Psoriatic Arthritis Therapeutics Drug Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Psoriatic Arthritis Therapeutics Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Psoriatic Arthritis Therapeutics Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Psoriatic Arthritis Therapeutics Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Psoriatic Arthritis Therapeutics Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Psoriatic Arthritis Therapeutics Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Psoriatic Arthritis Therapeutics Drug include Novartis, Eli Lilly, Pfizer, Amgen, AbbVie, UCB, Janssen Biotech, CELGENE CORPORATION and Bristol-Myers Squibb, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Psoriatic Arthritis Therapeutics Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Psoriatic Arthritis Therapeutics Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Psoriatic Arthritis Therapeutics Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Psoriatic Arthritis Therapeutics Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Psoriatic Arthritis Therapeutics Drug Segment by Company

Novartis

Eli Lilly

Pfizer

Amgen

AbbVie

UCB

Janssen Biotech

CELGENE CORPORATION

Bristol-Myers Squibb

Biogen

Psoriatic Arthritis Therapeutics Drug Segment by Type

Interleukin Inhibitors

NF Inhibitors

PDE4 Inhibitors

Others

Psoriatic Arthritis Therapeutics Drug Segment by Application

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

Psoriatic Arthritis Therapeutics Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Psoriatic Arthritis Therapeutics Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Psoriatic Arthritis Therapeutics Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Psoriatic Arthritis Therapeutics Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Psoriatic Arthritis Therapeutics Drug market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Psoriatic Arthritis Therapeutics Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Psoriatic Arthritis Therapeutics Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Psoriatic Arthritis Therapeutics Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Psoriatic Arthritis Therapeutics Drug Industry Trends Table 2. Psoriatic Arthritis Therapeutics Drug Industry Drivers Table 3. Psoriatic Arthritis Therapeutics Drug Industry Opportunities and Challenges Table 4. Psoriatic Arthritis Therapeutics Drug Industry Restraints Table 5. Global Psoriatic Arthritis Therapeutics Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Psoriatic Arthritis Therapeutics Drug Sales by Manufacturers (W Units) & (2021-2026) Table 8. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Manufacturers Table 9. Global Psoriatic Arthritis Therapeutics Drug Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Psoriatic Arthritis Therapeutics Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Psoriatic Arthritis Therapeutics Drug Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Psoriatic Arthritis Therapeutics Drug Manufacturers, Product Type & Application Table 13. Global Psoriatic Arthritis Therapeutics Drug Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Psoriatic Arthritis Therapeutics Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Interleukin Inhibitors Table 17. Major Manufacturers of NF Inhibitors Table 18. Major Manufacturers of PDE4 Inhibitors Table 19. Major Manufacturers of Others Table 20. Global Psoriatic Arthritis Therapeutics Drug Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 21. Global Psoriatic Arthritis Therapeutics Drug Sales by Type (2021-2026) & (W Units) Table 22. Global Psoriatic Arthritis Therapeutics Drug Sales by Type (2027-2032) & (W Units) Table 23. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type (2021-2026) Table 24. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type (2027-2032) Table 25. Global Psoriatic Arthritis Therapeutics Drug Revenue by Type 2021 VS 2025 VS 2032 (W Units) Table 26. Global Psoriatic Arthritis Therapeutics Drug Revenue by Type (2021-2026) & (W Units) Table 27. Global Psoriatic Arthritis Therapeutics Drug Revenue by Type (2027-2032) & (W Units) Table 28. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Type (2021-2026) Table 29. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Retail Pharmacies Table 31. Major Manufacturers of Online Pharmacies Table 32. Major Manufacturers of Hospital Pharmacies Table 33. Global Psoriatic Arthritis Therapeutics Drug Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 34. Global Psoriatic Arthritis Therapeutics Drug Sales by Application (2021-2026) & (W Units) Table 35. Global Psoriatic Arthritis Therapeutics Drug Sales by Application (2027-2032) & (W Units) Table 36. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application (2021-2026) Table 37. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application (2027-2032) Table 38. Global Psoriatic Arthritis Therapeutics Drug Revenue by Application 2021 VS 2025 VS 2032 (W Units) Table 39. Global Psoriatic Arthritis Therapeutics Drug Revenue by Application (2021-2026) & (W Units) Table 40. Global Psoriatic Arthritis Therapeutics Drug Revenue by Application (2027-2032) & (W Units) Table 41. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Application (2021-2026) Table 42. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Application (2027-2032) Table 43. Global Psoriatic Arthritis Therapeutics Drug Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 44. Global Psoriatic Arthritis Therapeutics Drug Sales by Region (2021-2026) & (W Units) Table 45. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Region (2021-2026) Table 46. Global Psoriatic Arthritis Therapeutics Drug Sales Forecasted by Region (2027-2032) & (W Units) Table 47. Global Psoriatic Arthritis Therapeutics Drug Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Psoriatic Arthritis Therapeutics Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 49. North America Psoriatic Arthritis Therapeutics Drug Sales by Country (2021-2026) & (W Units) Table 50. North America Psoriatic Arthritis Therapeutics Drug Sales by Country (2027-2032) & (W Units) Table 51. Europe Psoriatic Arthritis Therapeutics Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 52. Europe Psoriatic Arthritis Therapeutics Drug Sales by Country (2021-2026) & (W Units) Table 53. Europe Psoriatic Arthritis Therapeutics Drug Sales by Country (2027-2032) & (W Units) Table 54. Asia Pacific Psoriatic Arthritis Therapeutics Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 55. Asia Pacific Psoriatic Arthritis Therapeutics Drug Sales by Country (2021-2026) & (W Units) Table 56. Asia Pacific Psoriatic Arthritis Therapeutics Drug Sales by Country (2027-2032) & (W Units) Table 57. South America, Middle East and Africa Psoriatic Arthritis Therapeutics Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 58. South America, Middle East and Africa Psoriatic Arthritis Therapeutics Drug Sales by Country (2021-2026) & (W Units) Table 59. South America, Middle East and Africa Psoriatic Arthritis Therapeutics Drug Sales by Country (2027-2032) & (W Units) Table 60. Global Psoriatic Arthritis Therapeutics Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Psoriatic Arthritis Therapeutics Drug Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Psoriatic Arthritis Therapeutics Drug Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Region (2021-2026) Table 64. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Region (2027-2032) Table 65. Novartis Company Information Table 66. Novartis Business Overview Table 67. Novartis Psoriatic Arthritis Therapeutics Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Novartis Psoriatic Arthritis Therapeutics Drug Product Portfolio Table 69. Novartis Recent Development Table 70. Eli Lilly Company Information Table 71. Eli Lilly Business Overview Table 72. Eli Lilly Psoriatic Arthritis Therapeutics Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Eli Lilly Psoriatic Arthritis Therapeutics Drug Product Portfolio Table 74. Eli Lilly Recent Development Table 75. Pfizer Company Information Table 76. Pfizer Business Overview Table 77. Pfizer Psoriatic Arthritis Therapeutics Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Pfizer Psoriatic Arthritis Therapeutics Drug Product Portfolio Table 79. Pfizer Recent Development Table 80. Amgen Company Information Table 81. Amgen Business Overview Table 82. Amgen Psoriatic Arthritis Therapeutics Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Amgen Psoriatic Arthritis Therapeutics Drug Product Portfolio Table 84. Amgen Recent Development Table 85. AbbVie Company Information Table 86. AbbVie Business Overview Table 87. AbbVie Psoriatic Arthritis Therapeutics Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. AbbVie Psoriatic Arthritis Therapeutics Drug Product Portfolio Table 89. AbbVie Recent Development Table 90. UCB Company Information Table 91. UCB Business Overview Table 92. UCB Psoriatic Arthritis Therapeutics Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. UCB Psoriatic Arthritis Therapeutics Drug Product Portfolio Table 94. UCB Recent Development Table 95. Janssen Biotech Company Information Table 96. Janssen Biotech Business Overview Table 97. Janssen Biotech Psoriatic Arthritis Therapeutics Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Janssen Biotech Psoriatic Arthritis Therapeutics Drug Product Portfolio Table 99. Janssen Biotech Recent Development Table 100. CELGENE CORPORATION Company Information Table 101. CELGENE CORPORATION Business Overview Table 102. CELGENE CORPORATION Psoriatic Arthritis Therapeutics Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. CELGENE CORPORATION Psoriatic Arthritis Therapeutics Drug Product Portfolio Table 104. CELGENE CORPORATION Recent Development Table 105. Bristol-Myers Squibb Company Information Table 106. Bristol-Myers Squibb Business Overview Table 107. Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Drug Product Portfolio Table 109. Bristol-Myers Squibb Recent Development Table 110. Biogen Company Information Table 111. Biogen Business Overview Table 112. Biogen Psoriatic Arthritis Therapeutics Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Biogen Psoriatic Arthritis Therapeutics Drug Product Portfolio Table 114. Biogen Recent Development Table 115. Key Raw Materials Table 116. Raw Materials Key Suppliers Table 117. Psoriatic Arthritis Therapeutics Drug Distributors List Table 118. Psoriatic Arthritis Therapeutics Drug Customers List Table 119. Research Programs/Design for This Report Table 120. Authors List of This Report Table 121. Secondary Sources Table 122. Primary Sources List of Figures Figure 1. Psoriatic Arthritis Therapeutics Drug Product Image Figure 2. Global Psoriatic Arthritis Therapeutics Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Psoriatic Arthritis Therapeutics Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Psoriatic Arthritis Therapeutics Drug Sales (2021-2032) & (W Units) Figure 5. Global Psoriatic Arthritis Therapeutics Drug Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Psoriatic Arthritis Therapeutics Drug Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Interleukin Inhibitors Image Figure 9. NF Inhibitors Image Figure 10. PDE4 Inhibitors Image Figure 11. Others Image Figure 12. Global Psoriatic Arthritis Therapeutics Drug Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 13. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type (2021-2032) Figure 15. Global Psoriatic Arthritis Therapeutics Drug Revenue by Type (2021 VS 2025 VS 2032) & (W Units) Figure 16. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Type (2021-2032) Figure 18. Retail Pharmacies Image Figure 19. Online Pharmacies Image Figure 20. Hospital Pharmacies Image Figure 21. Global Psoriatic Arthritis Therapeutics Drug Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 22. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application (2021-2032) Figure 24. Global Psoriatic Arthritis Therapeutics Drug Revenue by Application (2021 VS 2025 VS 2032) & (W Units) Figure 25. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Application (2021-2032) Figure 27. North America Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 28. North America Psoriatic Arthritis Therapeutics Drug Sales Market Share by Country (2021-2032) Figure 29. U.S. Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 30. Canada Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 31. Mexico Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 32. Europe Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 33. Europe Psoriatic Arthritis Therapeutics Drug Sales Market Share by Country (2021-2032) Figure 34. Germany Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 35. France Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 36. U.K. Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 37. Italy Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 38. Netherlands Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 39. Asia Pacific Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 40. Asia Pacific Psoriatic Arthritis Therapeutics Drug Sales Market Share by Country (2021-2032) Figure 41. China Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 42. Japan Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 43. South Korea Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 44. Southeast Asia Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 45. India Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 46. Australia Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 47. South America, Middle East and Africa Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 48. South America, Middle East and Africa Psoriatic Arthritis Therapeutics Drug Sales Market Share by Country (2021-2032) Figure 49. Brazil Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 50. South Africa Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 51. Saudi Arabia Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 52. Turkey Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 53. Argentina Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 54. UAE Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 55. Egypt Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 56. Chile Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 57. Global Psoriatic Arthritis Therapeutics Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Psoriatic Arthritis Therapeutics Drug Revenue (2021-2032) & (US$ Million) Figure 60. North America Psoriatic Arthritis Therapeutics Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Psoriatic Arthritis Therapeutics Drug Revenue (2021-2032) & (US$ Million) Figure 62. Europe Psoriatic Arthritis Therapeutics Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Psoriatic Arthritis Therapeutics Drug Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Psoriatic Arthritis Therapeutics Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Psoriatic Arthritis Therapeutics Drug Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Psoriatic Arthritis Therapeutics Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Psoriatic Arthritis Therapeutics Drug Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Psoriatic Arthritis Therapeutics Drug Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Interleukin Inhibitors
  • NF Inhibitors
  • PDE4 Inhibitors
  • Others
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
Companies covered
  • Novartis
  • Eli Lilly
  • Pfizer
  • Amgen
  • AbbVie
  • UCB
  • Janssen Biotech
  • CELGENE CORPORATION
  • Bristol-Myers Squibb
  • Biogen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Psoriatic Arthritis Therapeutics Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Psoriatic Arthritis Therapeutics Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Psoriatic Arthritis Therapeutics Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Psoriatic Arthritis Therapeutics Drug Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Psoriatic Arthritis Therapeutics Drug Market Dynamics
  1. 2.1 Psoriatic Arthritis Therapeutics Drug Industry Trends
  2. 2.2 Psoriatic Arthritis Therapeutics Drug Industry Drivers
  3. 2.3 Psoriatic Arthritis Therapeutics Drug Industry Opportunities and Challenges
  4. 2.4 Psoriatic Arthritis Therapeutics Drug Industry Restraints
3 Psoriatic Arthritis Therapeutics Drug Market by Manufacturers
  1. 3.1 Global Psoriatic Arthritis Therapeutics Drug Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Psoriatic Arthritis Therapeutics Drug Sales by Manufacturers (2021-2026)
  3. 3.3 Global Psoriatic Arthritis Therapeutics Drug Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Psoriatic Arthritis Therapeutics Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Psoriatic Arthritis Therapeutics Drug Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Psoriatic Arthritis Therapeutics Drug Manufacturers, Product Type & Application
  7. 3.7 Global Psoriatic Arthritis Therapeutics Drug Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Psoriatic Arthritis Therapeutics Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Psoriatic Arthritis Therapeutics Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Psoriatic Arthritis Therapeutics Drug Tier 1, Tier 2, and Tier 3
4 Psoriatic Arthritis Therapeutics Drug Market by Type
  1. 4.1 Psoriatic Arthritis Therapeutics Drug Type Introduction
  2. 4.1.1 Interleukin Inhibitors
  3. 4.1.2 NF Inhibitors
  4. 4.1.3 PDE4 Inhibitors
  5. 4.1.4 Others
  6. 4.2 Global Psoriatic Arthritis Therapeutics Drug Sales by Type
  7. 4.2.1 Global Psoriatic Arthritis Therapeutics Drug Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Psoriatic Arthritis Therapeutics Drug Sales by Type (2021-2032)
  9. 4.2.3 Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type (2021-2032)
  10. 4.3 Global Psoriatic Arthritis Therapeutics Drug Revenue by Type
  11. 4.3.1 Global Psoriatic Arthritis Therapeutics Drug Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Psoriatic Arthritis Therapeutics Drug Revenue by Type (2021-2032)
  13. 4.3.3 Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Type (2021-2032)
5 Psoriatic Arthritis Therapeutics Drug Market by Application
  1. 5.1 Psoriatic Arthritis Therapeutics Drug Application Introduction
  2. 5.1.1 Retail Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Hospital Pharmacies
  5. 5.2 Global Psoriatic Arthritis Therapeutics Drug Sales by Application
  6. 5.2.1 Global Psoriatic Arthritis Therapeutics Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Psoriatic Arthritis Therapeutics Drug Sales by Application (2021-2032)
  8. 5.2.3 Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application (2021-2032)
  9. 5.3 Global Psoriatic Arthritis Therapeutics Drug Revenue by Application
  10. 5.3.1 Global Psoriatic Arthritis Therapeutics Drug Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Psoriatic Arthritis Therapeutics Drug Revenue by Application (2021-2032)
  12. 5.3.3 Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Application (2021-2032)
6 Global Psoriatic Arthritis Therapeutics Drug Sales by Region
  1. 6.1 Global Psoriatic Arthritis Therapeutics Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Psoriatic Arthritis Therapeutics Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Psoriatic Arthritis Therapeutics Drug Sales by Region (2021-2026)
  4. 6.2.2 Global Psoriatic Arthritis Therapeutics Drug Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Psoriatic Arthritis Therapeutics Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Psoriatic Arthritis Therapeutics Drug Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Psoriatic Arthritis Therapeutics Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Psoriatic Arthritis Therapeutics Drug Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Psoriatic Arthritis Therapeutics Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Psoriatic Arthritis Therapeutics Drug Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Psoriatic Arthritis Therapeutics Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Psoriatic Arthritis Therapeutics Drug Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Psoriatic Arthritis Therapeutics Drug Revenue by Region
  1. 7.1 Global Psoriatic Arthritis Therapeutics Drug Revenue by Region
  2. 7.1.1 Global Psoriatic Arthritis Therapeutics Drug Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Psoriatic Arthritis Therapeutics Drug Revenue by Region (2021-2026)
  4. 7.1.3 Global Psoriatic Arthritis Therapeutics Drug Revenue by Region (2027-2032)
  5. 7.1.4 Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Psoriatic Arthritis Therapeutics Drug Revenue (2021-2032)
  8. 7.2.2 North America Psoriatic Arthritis Therapeutics Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Psoriatic Arthritis Therapeutics Drug Revenue (2021-2032)
  11. 7.3.2 Europe Psoriatic Arthritis Therapeutics Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Psoriatic Arthritis Therapeutics Drug Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Psoriatic Arthritis Therapeutics Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Psoriatic Arthritis Therapeutics Drug Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Psoriatic Arthritis Therapeutics Drug Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Novartis
  2. 8.1.1 Novartis Company Information
  3. 8.1.2 Novartis Business Overview
  4. 8.1.3 Novartis Psoriatic Arthritis Therapeutics Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Novartis Psoriatic Arthritis Therapeutics Drug Product Portfolio
  6. 8.1.5 Novartis Recent Developments
  7. 8.2 Eli Lilly
  8. 8.2.1 Eli Lilly Company Information
  9. 8.2.2 Eli Lilly Business Overview
  10. 8.2.3 Eli Lilly Psoriatic Arthritis Therapeutics Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Eli Lilly Psoriatic Arthritis Therapeutics Drug Product Portfolio
  12. 8.2.5 Eli Lilly Recent Developments
  13. 8.3 Pfizer
  14. 8.3.1 Pfizer Company Information
  15. 8.3.2 Pfizer Business Overview
  16. 8.3.3 Pfizer Psoriatic Arthritis Therapeutics Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Psoriatic Arthritis Therapeutics Drug Product Portfolio
  18. 8.3.5 Pfizer Recent Developments
  19. 8.4 Amgen
  20. 8.4.1 Amgen Company Information
  21. 8.4.2 Amgen Business Overview
  22. 8.4.3 Amgen Psoriatic Arthritis Therapeutics Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Amgen Psoriatic Arthritis Therapeutics Drug Product Portfolio
  24. 8.4.5 Amgen Recent Developments
  25. 8.5 AbbVie
  26. 8.5.1 AbbVie Company Information
  27. 8.5.2 AbbVie Business Overview
  28. 8.5.3 AbbVie Psoriatic Arthritis Therapeutics Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 AbbVie Psoriatic Arthritis Therapeutics Drug Product Portfolio
  30. 8.5.5 AbbVie Recent Developments
  31. 8.6 UCB
  32. 8.6.1 UCB Company Information
  33. 8.6.2 UCB Business Overview
  34. 8.6.3 UCB Psoriatic Arthritis Therapeutics Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 UCB Psoriatic Arthritis Therapeutics Drug Product Portfolio
  36. 8.6.5 UCB Recent Developments
  37. 8.7 Janssen Biotech
  38. 8.7.1 Janssen Biotech Company Information
  39. 8.7.2 Janssen Biotech Business Overview
  40. 8.7.3 Janssen Biotech Psoriatic Arthritis Therapeutics Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Janssen Biotech Psoriatic Arthritis Therapeutics Drug Product Portfolio
  42. 8.7.5 Janssen Biotech Recent Developments
  43. 8.8 CELGENE CORPORATION
  44. 8.8.1 CELGENE CORPORATION Company Information
  45. 8.8.2 CELGENE CORPORATION Business Overview
  46. 8.8.3 CELGENE CORPORATION Psoriatic Arthritis Therapeutics Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 CELGENE CORPORATION Psoriatic Arthritis Therapeutics Drug Product Portfolio
  48. 8.8.5 CELGENE CORPORATION Recent Developments
  49. 8.9 Bristol-Myers Squibb
  50. 8.9.1 Bristol-Myers Squibb Company Information
  51. 8.9.2 Bristol-Myers Squibb Business Overview
  52. 8.9.3 Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Drug Product Portfolio
  54. 8.9.5 Bristol-Myers Squibb Recent Developments
  55. 8.10 Biogen
  56. 8.10.1 Biogen Company Information
  57. 8.10.2 Biogen Business Overview
  58. 8.10.3 Biogen Psoriatic Arthritis Therapeutics Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Biogen Psoriatic Arthritis Therapeutics Drug Product Portfolio
  60. 8.10.5 Biogen Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Psoriatic Arthritis Therapeutics Drug Value Chain Analysis
  2. 9.1.1 Psoriatic Arthritis Therapeutics Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Psoriatic Arthritis Therapeutics Drug Production Mode & Process
  6. 9.2 Psoriatic Arthritis Therapeutics Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Psoriatic Arthritis Therapeutics Drug Distributors
  9. 9.2.3 Psoriatic Arthritis Therapeutics Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst